Limited Time Deal! Holiday Season Sale
Huge savings upto 65% on WordPress plugins, themes, SEO, marketing, software solutions and more.

Get 100+ Exclusive Deals

Germany has authorized its first clinical test of a vaccine for the novel coronavirus, the country’s regulatory body said on Wednesday, green-lighting trials on human volunteers for an RNA vaccine developed by German firm Biontech and US giant Pfizer.

“The Paul-Ehrlich-Institut… has authorised the first clinical trial of a vaccine against COVID-19 in Germany,” the regulatory body said in a statement.

It added that approval was the “result of a careful assessment of the potential risk/benefit profile of the vaccine candidate”.

Sign up for Newsletters

Subscribe to our newsletter and never miss an update on the latest tech, gaming, startup, how to guide, deals and more.